Alzheimer’s Therapy
Tech ID
P27-1242
Patent Status
Granted in India
Design Status
--
Technical Description
The present invention provides a novel compound 2-(4-Bromophenyl)-5-(4-(pyridin-2-yl) 5 piperazin-1-yl)-1,3,4-oxadiazole which has multi-functional potential against Alzheimer’s disease.
Problems Addressed
- Aβ Accumulation in Brain
- Limitations of Existing Treatments
- Poor Drug Efficacy
- No Multitargeted Molecules
TARGET AUDIENCE
- Healthcare & Medical Sector
- Pharmaceutical Industry
- Biotechnology Firms
- Research and Development
TECH FEATURES
- Novel Compound
- Multitargeted Ligand
- Inhibits Cholinesterases & BACE-1
- Neuroprotective Against Aβ-Induced Stress
- No Toxicity
- High Melting Point
- Enhanced BBB Permeability
- Anti-Aβ Aggregation Activity
P27-1242
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com